Unknown NA INTERVENTIONAL 2-arm NCT01680523

Radical Hysterectomy Followed by Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)

A Randomized Controlled Trial Comparing Radical Hysterectomy Plus Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)

Sponsor: Asan Medical Center

Conditions Cervical Cancer

Interventions Primary chemoradiation therapy Radical hysterectomy Tailored adjuvant therapy

Updated 8 times since 2017 Last updated: May 27, 2017 Started: Sep 30, 2012 Primary completion: Jul 31, 2020 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cervical Cancer, this trial is ongoing. The trial is conducted by Asan Medical Center and has accumulated 8 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Aug 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Aug 2020 [monthly]

Recruiting NA
Jul 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Jul 2017 [monthly]

Recruiting NA

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asan Medical Center

Data source: Asan Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea